← Eichor
Condition: Moderate To Severe Rheumatoid Arthritis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Moderate To Severe Rheumatoid Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severel
Phase 2 · 1 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07423533The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07001956A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Phase 2 · 104 location(s) · AbbVie · NCT06972446Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
Phase 1 · 7 location(s) · Lifordi Immunotherapeutics, Inc. · NCT07207954Korean Post-marketing Surveillance for Xeljanz XR
Phase N/A · 1 location(s) · Pfizer · NCT04876781MTS109 in Patients With Refractory Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Shanghai Changzheng Hospital · NCT07526350A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Phase N/A · 53 location(s) · AbbVie · NCT06712628A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Phase 1 · 11 location(s) · Cullinan Therapeutics Inc. · NCT07041099A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who
Phase 2 · 56 location(s) · Hoffmann-La Roche · NCT07137598A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enb
Phase 3 · 60 location(s) · mAbxience Research S.L. · NCT06596772The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid
NA · 3 location(s) · The Bionics Institute of Australia · NCT07017686A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (R
Phase 1 · 3 location(s) · Capstan Therapeutics · NCT06917742Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis
Phase 2 · 6 location(s) · Toll Biotech Co. Ltd. (Beijing) · NCT07408024Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Trea
Phase 4 · 1 location(s) · Shaikh Zayed Hospital, Lahore · NCT07554820A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · 144 location(s) · AstraZeneca · NCT07276581A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to S
Phase 1 · 1 location(s) · Shanghai Qilu Pharmaceutical Research and Development Center · NCT06946641
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.